Announcements Trials

Browse Landscape

Phase

Phase 3 6 Phase 2 6 Phase 1 3 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 47 Prostatic Neoplasms 33 Breast Neoplasms 23 Stomach Neoplasms 16 Squamous Cell Carcinoma of Head and Neck 15 Lung Neoplasms 15 Esophageal Neoplasms 13 Neoplasm Metastasis 11 Sarcoma 9 Neoplasms 9 Colorectal Neoplasms 7 Urinary Bladder Neoplasms 6 Ovarian Neoplasms 6 Head and Neck Neoplasms 6 Carcinoma, Transitional Cell 6 Carcinoma, Renal Cell 6 Melanoma 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Small Cell Lung Carcinoma 4 Carcinoma, Ovarian Epithelial 4 Breast Neoplasms, Male 4 Salivary Gland Neoplasms 3 Prostatic Neoplasms, Castration-Resistant 3 Pancreatic Neoplasms 3 Non-Muscle Invasive Bladder Neoplasms 3 Leiomyosarcoma 3 Inflammatory Breast Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Squamous Cell 3

Interventions

pembrolizumab 12 Cisplatin 5 Cetuximab 5 Paclitaxel 4 durvalumab 3 Nivolumab 3 Ipilimumab 3 Gemcitabine 3 Cyclophosphamide 3 poly ICLC 2 avelumab 2 Radiation 2 Pemetrexed 2 Leucovorin 2 Irinotecan 2 Fluorouracil 2 Carboplatin 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 vistusertib 1 tislelizumab 1 tirbanibulin 1 spartalizumab 1 sonidegib 1 sitravatinib 1 repotrectinib 1 pralsetinib 1 pertuzumab 1 pepinemab 1 obinutuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Carcinoma × Docetaxel × Clear all

NCT04151563 2023-12-19

CheckMate 79X

Bristol-Myers Squibb

Phase 1/2 Withdrawn

Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡